Effect of sorafenib on the energy metabolism of hepatocellular carcinoma cells

European Journal of Pharmacology

Volumn 670, Issue 1, 2011, Pages 39-43

  Fiume, Luigi ^a   Manerba, Marcella ^a   Vettraino, Marina ^a   Di Stefano, Giuseppina ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Aerobic glycolysis; Hepatocellular carcinoma chemotherapy; Keywords; Sorafenib; Tumor cell metabolism

Indexed keywords

ADENOSINE TRIPHOSPHATE; GLUCOSE; LACTIC ACID; OXYGEN; SORAFENIB;

AEROBIC GLYCOLYSIS; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL LEVEL; CELL METABOLISM; CELL STIMULATION; CELL STRAIN PLC PRF 5; CELL STRAIN SNU 449; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DEPLETION; ENERGY METABOLISM; GLYCOLYSIS; HUMAN; HUMAN CELL; IC 50; LIVER CELL CARCINOMA; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATE; AEROBIOSIS; ANTINEOPLASTIC AGENTS; BENZENESULFONATES; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; CELL RESPIRATION; CELL SURVIVAL; ENERGY METABOLISM; GLYCOSYLATION; HUMANS; LIVER NEOPLASMS; OXIDATIVE PHOSPHORYLATION; PYRIDINES;

EID: 80054743835     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.08.038     Document Type: Article

References (22)

1. J.J. Alexander, E.M. Bey, E.W. Geddes, and G. Lecatsas Establishment of a continuously growing cell line from primary carcinoma of the liver S. Afr. Med. J. 50 1976 2124 2128 (Pubitemid 8004296)
2. S.B. Barker, and W.H. Summerson The colorimetric determination of lactic acid in biological material J. Biol. Chem. 138 1941 535 554
3. J.M. Cuezva, M. Krajewska, M.L. de Heredia, S. Krajewski, G. Santamaría, H. Kim, J.M. Zapata, H. Marusawa, M. Chamorro, and J.C. Reed The bioenergetic signature of cancer: a marker of tumor progression Cancer Res. 62 2002 6674 6681 (Pubitemid 35364137)
4. L. Fiume, M. Manerba, M. Vettraino, and G. Di Stefano Impairment of aerobic glycolysis by inhibitors of lactic dehydrogenase hinders the growth of human hepatocellular carcinomas cell lines Pharmacology 86 2010 157 162
5. G. Fotakis, and J.A. Timbrell In vitro cytotoxicity assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride Toxicol. Lett. 160 2006 171 177 (Pubitemid 41578961)
6. E.B. Goldberg, H.M. Nitowsky, and S.P. Colowick The role of glycolysis in the growth of tumor cells. IV. The basis of glucose toxicity in oxamate-treated cultured cells J. Biol. Chem. 240 1965 2791 2796
7. C. Granchi, S. Bertini, M. Macchia, and F. Minutolo Inhibitors of lactate dehydrogenase isoforms and their therapeutic potential Curr. Med. Chem. 17 2010 672 697
8. H.A. Krebs The Pasteur effect and the relations between respiration and fermentation Essays Biochem. 8 1972 1 34
9. W. Lieberthal, S.A. Menza, and J.S. Levine Graded ATP depletion can cause necrosis or apoptosis of cultured mouse proximal tubular cells Am. J. Physiol. Renal Physiol. 274 1998 F315 F327
10. L. Liu, Y. Cao, C. Chen, X. Zhang, A. McNabola, D. Wilkie, S. Wilhelm, M. Lynch, and C. Carter Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5 Cancer Res. 66 2006 11851 11858 (Pubitemid 46094197)
11. J.M. Llovet, S. Ricci, V. Mazzaferro, P. Hilgard, E. Gane, J.F. Blanc, A.C. de Oliveira, A. Santoro, J.L. Raoul, A. Forner, M. Schwartz, C. Porta, S. Zeuzem, L. Bolondi, T.F. Greten, P.R. Galle, J.F. Seitz, I. Borbath, D. Häussinger, T. Giannaris, M. Shan, M. Moscovici, D. Voliotis, J. Bruix SHARP Investigators Study Group l Sorafenib in advanced hepatocellular carcinoma N. Engl. J. Med. 359 2008 378 390
12. L.D. Marroquin, J. Hynes, J.A. Dykens, J.D. Jamieson, and Y. Will Circumventing the Crabtree effect: replacing media glucose with galactose increases susceptibility of HepG2 cells to mitochondrial toxicants Toxicol. Sci. 97 2007 539 547 (Pubitemid 47073868)
13. W.B. Novoa, A.D. Winer, A.J. Glaid, and G.W. Schwert Lactic dehydrogenase. V. Inhibition by oxamate and by oxalate J. Biol. Chem. 234 1959 1143 1148
14. J. Papacostantinou, and S.P. Colowick The role of glycolysis in the growth of tumor cells. II. The effect of oxamic acid on the growth of HeLa cells in tissue culture J. Biol. Chem. 236 1961 285 288
15. J.G. Park, J.H. Lee, M.S. Kang, K.J. Park, Y.M. Jeon, H.J. Lee, H.S. Kwon, H.S. Park, K.S. Yeo, and K.U. Lee Characterization of cell lines established from human hepatocellular carcinoma Int. J. Cancer 62 1995 276 282
16. H. Pelicano, D.S. Martin, R.H. Xu, and P. Huang Glycolysis inhibition for anticancer treatment Oncogene 25 2006 4633 4646 (Pubitemid 44187614)
17. L.J. Reitzer, B.M. Wice, and D. Kennell Evidence that glutamine, not sugar, is the major energy source of cultured HeLa cells J. Biol. Chem. 254 1979 2669 2676 (Pubitemid 9196102)
18. R. Rossignol, R. Gilkerson, R. Aggeler, K. Yamagata, S.J. Remington, and R.A. Capaldi Energy substrate modulates mitochondrial structure and oxidative capacity in cancer cells Cancer Res. 64 2004 985 993 (Pubitemid 38176901)
19. J.S. Sebolt-Leopold, and J.M. English Mechanisms of drug inhibition of signalling molecules Nature 441 2006 457 462 (Pubitemid 44050141)
20. D. Strumberg, H. Richly, R.A. Hilger, N. Schleucher, S. Korfee, M. Tewes, M. Faghih, E. Brendel, D. Voliotis, C.G. Haase, B. Schwartz, A. Awada, R. Voigtmann, M.E. Scheulen, and S. Seeber Phase I clinical and pharmacokinetic study of the novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors J. Clin. Oncol. 23 2005 965 972 (Pubitemid 46202316)
21. D. Strumberg, J.W. Clark, A. Awada, M.J. Moore, H. Richly, A. Hendlisz, H.W. Hirte, J.P. Eder, H.J. Lenz, and B. Schwartz Safety, pharmacokinetics, and preliminary antitumor activity of sorafenib: a review of four phase I trials in patients with advanced refractory solid tumors Oncologist 12 2007 426 437 (Pubitemid 46698720)
22. Y. Will, J.A. Dykens, S. Nadanaciva, B. Hirakawa, J. Jamieson, L.D. Marroquin, J. Hynes, S. Patyna, and B.A. Jessen Effect of the multitargeted tyrosine kinase inhibitors imatinib, desatinib, sunitinib and sorafenib on mitochondrial function in isolated rat heart mitochondria and H9c2 cells Toxicol. Sci. 106 2008 153 161